This is a preview and has not been published.




Dietary phytochemical index, breast cancer, obesity


Introduction: Breast cancer is one of the most common cancers globally and has been reported as the leading cause of cancer-related death in women. Obesity is defined as one of the most important risk factors for breast cancer. On the other hand, oncological studies have reported that regular daily consumption of phytochemicals can reduce the risk of breast cancer. Therefore, this study aimed to clarify the association between obesity, dietary phytochemical index (DPI), and breast cancer risk (BCR) and knowledge level (BCKL).

Methods: This observational study was conducted with women aged 18-65 years. Participants filled out sociodemographic and lifestyle characteristics, anthropometric data, breast cancer risk and knowledge level scales via Google forms. Body weight, height, and waist circumference (WC) were declared by the participants. BMI, waist to height ratio (WtHr), dietary phytochemical index, BCR and BCKL calculations were made by the researchers. Food consumption was recorded with a 24-hour dietary recall.

Results: In terms of BCR, 94.2% of the participants were in the low, 3.3% in the medium, 0.3% in the high, and 2.2% in the highest risk group. Besides, there were significant differences between body weight, height, BMI, WC, WtHr values of BCR groups. However, no significant difference was observed between the DPI consumption of BCR groups. Besides, DPI was not associated with BMI, WC, BCR, and BCKL.  On the other hand, BMI was correlated (moderate to strong) with WC and BCR (r=0.719 and r=0.605, respectively). Also, WC was significantly correlated (moderate) with BCR (r=0.475). The association between WC and BCKL (rs=0.088) was statistically significant but not clinically significant.

Conclusion: In conclusion, although BCR was not associated with DPI, it was associated with BMI and WC values, which are the indicators of obesity. In the light of this information, the associations between obesity, DPI, BCR, and BCKL will be understood more clearly in future studies with a large sample in which BCR groups have an equal distribution.


Download data is not yet available.


Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). The Breast. 2012; 21(3): 242-52.

Aslan FE, Gürkan A. Kadinlarda meme kanseri risk düzeyi. Meme Sağliği Dergisi. 2007; 3: 63-8.

Group EBCTC. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. The Lancet. 2012; 379(9814): 432-44.

Karayurt Ö, Zorukoş SN. Meme kanseri riski yüksek olan kadinlarin yaşadiklari duygular ve bilgi-destek gereksinimlerinin karşilanmasi. Meme Sagligi Dergisi/Journal of Breast Health. 2008; 4(2).

Tümer A, Baybek H. Çalışan kadınlarda meme kanseri risk düzeyi. Meme Sağlığı Dergisi. 2010; 6(1): 17-21.

Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. Jama. 2006; 296(2): 193-201.

McKenzie F, Ferrari P, Freisling H, Chajès V, Rinaldi S, De Batlle J, et al. Healthy lifestyle and risk of breast cancer among postmenopausal women in the E uropean P rospective I nvestigation into C ancer and N utrition cohort study. International journal of cancer. 2015; 136(11): 2640-8.

Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA oncology. 2015; 1(5): 611-21.

Liu RH, Hotchkiss JH. Potential genotoxicity of chronically elevated nitric oxide: a review. Mutation Research/Reviews in Genetic Toxicology. 1995; 339(2): 73-89.

Moulder S, Hortobagyi G. Advances in the treatment of breast cancer. Clinical Pharmacology & Therapeutics. 2008; 83(1): 26-36.

Isakoff SJ. Triple negative breast cancer: role of specific chemotherapy agents. Cancer journal (Sudbury, Mass). 2010; 16(1): 53.

Cazzaniga M, Bonanni B. Breast cancer chemoprevention: old and new approaches. Journal of Biomedicine and Biotechnology. 2012; 2012.

Tan AC, Konczak I, Sze DM-Y, Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutrition and cancer. 2011; 63(4): 495-505.

Waladkhani A, Clemens MR. Effect of dietary phytochemicals on cancer development. International Journal of Molecular Medicine. 1998; 1(4): 747-800.

Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. Journal of agricultural and food chemistry. 2001; 49(11): 5315-21.

Casagrande F, Darbon J-M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochemical pharmacology. 2001; 61(10): 1205-15.

Vijayababu M, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas M, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Journal of cancer research and clinical oncology. 2005; 131(11): 765-71.

Tan KW, Li Y, Paxton JW, Birch NP, Scheepens A. Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Food chemistry. 2013; 138(4): 2267-74.

Chen P, Li C, Li X, Li J, Chu R, Wang H. Higher dietary folate intake reduces the breast cancer risk: a systematic review and meta-analysis. British journal of cancer. 2014; 110(9): 2327-38.

Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, et al. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon e in women with hormone receptor–negative breast cancer. Cancer prevention research. 2012; 5(9): 1144-54.

Toledo E, Salas-Salvadó J, Donat-Vargas C, Buil-Cosiales P, Estruch R, Ros E, et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial. JAMA internal medicine. 2015; 175(11): 1752-60.

Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. Epigenetic activation of BRCA1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward Aryl hydrocarbon receptor. Nutrients. 2019; 11(11): 2559.

Dastpeyman M, Motamed N, Azadmanesh K, Mostafavi E, Kia V, Jahanian-Najafabadi A, et al. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI. Medical Oncology. 2012; 29(4): 2512-8.

Mock CD, Jordan BC, Selvam C. Recent advances of curcumin and its analogues in breast cancer prevention and treatment. RSC advances. 2015; 5(92): 75575-88.

Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer. 2003; 3(10): 768-80.

Organization WH. Body Mass Index 2021 [Available from:

McCarty MF. Proposal for a dietary “phytochemical index”. Medical hypotheses. 2004; 63(5): 813-7.

TC Sağlık Bakanlığı Ana Çocuk Sağlığı, Ulusal Aile Planlaması Müdürlüğü. Ulusal Aile Planlaması Hizmet Rehberi. Ankara, TCSB Ana Çocuk Sağlığı ve Aile Planlaması Genel Müdürlüğü. 2000.

Spence W. Health EDCO. A Division of WRS Group. Inc, Waco, Texas. 2000.

Stager JL. The comprehensive breast cancer knowledge test: validity and reliability. Journal of advanced nursing. 1993;18(7):1133-40.

Başak, ŞC. Üniversite Öğrencilerinde Meme Kanseri Bilgi Seviyesi: Geniş Kapsamlı Meme Kanseri Bilgi Testi’nin Geçerlik Ve Güvenirlik Çalışması. Okan Üniversitesi Sosyal Bilimler Enstitüsü. Okan Universitesi Psikoloji Bölümü Yüksek Lisans Tezi Istanbul Türkiye. 2015.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016; 66(1): 7-30.

Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine (PhIP). Carcinogenesis. 1991; 12(8): 1503-6.

Onat H, Başaran M. Meme kanseri risk faktörleri ve koruma. Topuz E, Aydıner A, Dinçer Meme Kanseri. 2003; 1: 90-107.

Merkezleri. HKvK. What are the risk factors? [Available from:

Eroglu C, Eryilmaz MA, Civcik S, Gurbuz Z. Meme Kanseri Risk Değerlendirmesi: 5000 Olgu. International Journal of Hematology & Oncology/UHOD: Uluslararasi Hematoloji Onkoloji Dergisi. 2010; 20(2).

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. New England Journal of Medicine. 2003; 348(17): 1625-38.

Van den Brandt PA, Spiegelman D, Yaun S-S, Adami H-O, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. American journal of epidemiology. 2000; 152(6): 514-27.

Gaudet MM, Carter BD, Patel AV, Teras LR, Jacobs EJ, Gapstur SM. Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Cancer Causes & Control. 2014; 25(6): 737-45.

Kabat GC, Kim MY, Lee JS, Ho GY, Going SB, Beebe-Dimmer J, et al. Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women. Cancer Epidemiology and Prevention Biomarkers. 2017; 26(12): 1730-5.

Bodur S, Eryılmaz MA, Civcik S, Durduran Y. Kanserlerin toplumdaki dağılımının belirlenmesi ve insidansın tahmininde KETEM kayıtlarının katkısı: Konya örneği. Genel Tip Dergisi. 2011; 21(4).

Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN. Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast cancer research and treatment. 2011; 129(2): 565-74.

Lu Y, Ma H, Malone KE, Norman SA, Sullivan-Halley J, Strom BL, et al. Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. Journal of Clinical Oncology. 2011; 29(25): 3358.

De Waard F, Baanders‐van Halewijn E. A prospective study in general practice on breast‐cancer risk in postmenopausal women. International Journal of Cancer. 1974; 14(2): 153-60.

Castello A, Pollán M, Buijsse B, Ruiz A, Casas A, Baena-Cañada J, et al. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study. British journal of cancer. 2014; 111(7): 1454-62.

Bahadoran Z, Karimi Z, Houshiar-Rad A, Mirzayi H-R, Rashidkhani B. Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women. Asian Pacific Journal of Cancer Prevention. 2013; 14(5): 2747-51.

Warren BS, Devine C. Meat, Poultry and Fish and the Risk of Breast Cancer Fact Sheet No. 39. 2000.


Original articles

Most read articles by the same author(s)